SKYX Platforms Corp. — Director's Dealing 2023

Oct 2, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: SKYX Platforms Corp. (SKYX)
CIK: 0001598981
Period of Report: 2023-09-30

Reporting Person: SOKOLOW LEONARD J (Director, Co-Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-09-30	Common Stock, no par value	A	4133	$1.42	Acquired	781545	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Option (right to buy)	$0.6	2025-11-15	Common Stock, no par value (150000)	150000	Direct
Stock Option (right to buy)	$3	2027-04-19	Common Stock, no par value (150000)	150000	Direct
Stock Option (right to buy)	$4	2027-04-19	Common Stock, no par value (150000)	150000	Direct
Stock Option (right to buy)	$3	2024-01-01	Common Stock, no par value (100000)	100000	Direct
Stock Option (right to buy)	$12	2025-01-01	Common Stock, no par value (100000)	100000	Direct
Stock Option (right to buy)	$12	2025-12-31	Common Stock, no par value (100000)	100000	Direct
Stock Option (right to buy)	$12	2026-12-31	Common Stock, no par value (100000)	100000	Direct
Stock Option (right to buy)	$12.34	2027-03-11	Common Stock, no par value (17500)	17500	Direct
Stock Option (right to buy)	$3.28	2028-04-05	Common Stock, no par value (17500)	17500	Direct
Stock Option (right to buy)	$1.58	2028-09-12	Common Stock, no par value (450000)	450000	Direct
Warrant (right to buy)	$12	2023-12-31	Common Stock, no par value (4469)	4469	Direct
Warrant (right to buy)	$9.8	2024-10-26	Common Stock, no par value (1088)	1088	Direct
Warrant (right to buy)	$9.8	2024-11-29	Common Stock, no par value (3375)	3375	Direct
Warrant (right to buy)	$9.8	2024-12-22	Common Stock, no par value (19827)	19827	Direct
6.0% Subordinated Convertible Promissory Note	$15	2023-09-22	Common Stock, no par value ()		Direct

Footnotes

F1: Exercisable at any time on or prior to the expiration date at the holder's discretion at the initial exercise price of $12.00 per share, subject to adjustment provisions (including certain anti-dilution provisions).

F2: Exercisable at any time on or prior to the expiration date at the holder's discretion at the adjusted exercise price of $9.80 per share, subject to adjustment provisions (including certain anti-dilution provisions).

F3: The principal amount, plus any accrued and unpaid interest, is convertible into shares of common stock at any time on or prior to the maturity date at the holder's discretion at the conversion price of $15.00 per share.

F4: Represents the principal amount of the convertible note and excludes interest that may accrue. Interest on the note is payable annually, in cash or common stock, at the holder's discretion.

F5: Options vest in twelve equal monthly installments, beginning on the last day of the month in which the options were granted.

F6: Options vest over 3.5 years as follows, subject to continued employment through the vesting date: 120,000 vested on September 12, 2023; 300,000 vest in six semi-annual installments of 50,000, beginning on March 12, 2024; and 30,000 vest on March 12, 2027.

F7: Includes 20,167 restricted shares granted in consideration for services to be provided to the issuer pursuant to a corporate advisory agreement between the issuer and Newbridge Securities Corporation dated November 9, 2022. The restricted shares vest on the following schedule: one quarter of the shares on each of November 9, 2022 and the six-, 12- and 18-month anniversaries of such date. If the agreement is terminated prior to its expiration, any shares that have not vested as of such date will be forfeited.

F8: Includes 330,000 restricted stock units, which will vest as follows, subject to continued employment through the vesting date: 300,000 vest in six semi-annual installments of 50,000 beginning on March 12, 2024 and 30,000 vest on March 12, 2027.

F9: The reporting person previously elected to receive shares of the issuer's common stock in lieu of the cash retainer payable for service on the issuer's board of directors, pursuant to the non-employee director compensation program. The reporting person received a prorated number of shares representing compensation as a non-employee director prior to his appointment as Co-Chief Executive Officer of the issuer.